Open AccessP1013: OVERALL SURVIVAL IN PATIENTS WITH SYSTEMIC MASTOCYTOSIS WITH ASSOCIATED HEMATOLOGIC NEOPLASM TREATED WITH AVAPRITINIB VERSUS BEST AVAILABLE THERAPY
Author(s) -
Reiter A.,
Gotlib J.,
ÁlvarezTwose I.,
Radia D. H.,
Luebke J.,
Bobbili P. J.,
Wang A.,
Norregaard C.,
Dimitrijević S.,
Sullivan E.,
LouieGao M.,
Schwaab J.,
Galinsky I. A.,
Perkins C.,
Sperr W. R.,
Sriskandarajah P.,
Chin A.,
Sendhil S. R.,
Duh M. S.,
Valent P.,
DeAngelo D. J.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000846920.28798.b0
Subject(s) - medicine , systemic mastocytosis , randomized controlled trial , myeloproliferative neoplasm , clinical trial , observational study , anemia , survival analysis , pediatrics , bone marrow , myelofibrosis